Entecavir or tenofovir monotherapy prevents HBV recurrence in liver transplant recipients: A 5-year follow-up study after hepatitis B immunoglobulin withdrawal. Issue 1 (16th February 2017) - Manini, M.A.; Bruce, M.; Carey, I.; Whitehouse, G.; Wang, B.; Gonsalkorala, E.; Considine, A.; Lampertico, P.; Agarwal, K.